Showing posts with label drug safety. Show all posts
Showing posts with label drug safety. Show all posts

Wednesday, May 7, 2008

U.S. Food & Drug Administration (FDA) Daily Digest Bulletin

Update : 1
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 6 May 2008 03:35:51 -0500 (CDT)
Subject: CDER New 5/2/2008

FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

CDERnew Logo

May 2, 2008


Update: 2
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 6 May 2008 07:05:41 -0500 (CDT)
Subject: Hydrox Labs Issued a Voluntary Recall of Alcohol-Free Mouthwash Nationwide Distributed by Cardinal Health (May 2)

Hydrox Labs Issued a Voluntary Recall of Alcohol-Free Mouthwash Nationwide Distributed by Cardinal Health (May 2)
Tue, 6 May 2008 06:25:00 -0500

Hydrox Labs has issued a voluntary recall of Cardinal Health labeled alcohol-free mouthwash. The mouthwash has been tested and been found positive for Burkholderia cepacia (B. cepacia). The CDC has confirmed hospital illnesses in one state associated with the use of the affected mouthwash.


Update: 3
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 6 May 2008 07:49:59 -0500 (CDT)
Subject: CDRH New Update

Skip NavigationFDA Logo links to FDA home pageCenter for Devices and Radiological Health, U.S. Food and Drug AdministrationHHS Logo links to Department of Health and Human Services website

FDA Home Page | CDRH Home Page | Search | A-Z Index U.S. Food and Drug AdministrationCenter for Devices and Radiological Health Questions?
horizonal rule
CDRHNEW Logo Date: May 6, 2008

The following new items were added to the CDRH web pages on May 5, 2008. Previous CDRH New Items can be found on the CDRHNew Page.

* 510(k) Final Decisions - April 2008 Text

---


Update: 4
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 6 May 2008 13:03:51 -0500 (CDT)
Subject: Updated Press Release: Lezza Blue Raspberry Italian Ice Recalled

Updated Press Release: Lezza Blue Raspberry Italian Ice Recalled
Tue, 6 May 2008 12:25:00 -0500

The product is in round plastic pint containers with a lot code of 2116. Blue Raspberry is the flavor of the product. The product was distributed to retail outlets in Illinois, Wisconsin, Oklahoma, Texas, Michigan, Louisiana, Kansas, Indiana, Georgia, Florida, Ohio, Missouri, Kentucky, Nebraska, Pennsylvania, Arkansas, and Minnesota during 2006 and 2007.


Update: 5
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 6 May 2008 16:00:15 -0500 (CDT)
Subject: Recent Device Approvals: Thoratec HeartMate II Left Ventricular Assist System

You are subscribed to Recent Device Approvals updates for U.S. Food & Drug Administration (FDA). Information about the Thoratec HeartMate II Left Ventricular Assist System (LVAS) has recently been posted to the FDA website, and is now available.


Update: 6
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 6 May 2008 20:03:13 -0500 (CDT)
Subject: Blount Fine Foods Issues Allergy Alert On Undeclared Shrimp in All Natural New England Clam Chowder, 20 Oz Cup (May 6)

Blount Fine Foods Issues Allergy Alert On Undeclared Shrimp in All Natural New England Clam Chowder, 20 Oz Cup (May 6)
Tue, 6 May 2008 18:30:00 -0500

Blount Fine Foods is recalling Blount All Natural New England Clam Chowder, Net Wt. 20 oz with Lot: 0424086D, Sell by date: 6/23/2008, because it may contain undeclared shrimp. People who have an allergy or severe sensitivity to shrimp run the risk of serious or life-threatening allergic reaction if they consume these products. The firm has recovered 1,400 of 1,416 units produced, 16 units are in distribution.


Update: 7
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 6 May 2008 20:10:56 -0500 (CDT)
Subject: CDER New 5/6/2008

FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

CDERnew Logo

May 6, 2008


Update: 8
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 6 May 2008 08:05:39 -0500 (CDT)
Subject: FDA MedWatch - The May 2008 FDA Patient Safety News Is Now Available

MedWatch logo MedWatch - The FDA Safety Information and Adverse Event Reporting Program

FDA Patient Safety News (PSN) is a monthly video news show for healthcare professionals. It covers significant safety alerts, recalls, new product approvals, and offers important tips on protecting patients. Read the complete stories and watch or download the video program at http://www.fda.gov/psn. You may have already received notification of some of these safety issues through the MedWatch list serve. However, many of these PSN stories contain video footage and demonstrations that may be especially useful to educators in healthcare facilities and academic institutions.

Stories in the May 2008 edition include:

FDA Licenses New Hemophilia Treatment
Xyntha is produced without additives
from human or animal material, which can further minimize the risk of infection...

Unsafe Use of Extended-Release Tussionex Suspension
Overdose of long-acting hydrocodone cough suppressant can result in respiratory depression and death...

Liver Injury with Tysabri (natalizumab)
Tysabri should be discontinued in patients with jaundice or other evidence of significant liver injury...

Updated Labeling Changes for Tamiflu (oseltamivir phosphate) and Relenza (zanamivir)
Patients with influenza should be closely monitored for signs of abnormal behavior...

New Instructions for Using Talecris IG Syringes
How to use HyperRAB S/D and GamaSTAN S/D 2 mL syringes properly in certain circumstances...

Hepatotoxicity with Prezista (darunavir)
Appropriate laboratory testing should be conducted before starting treatment and patients should also be monitored during treatment...

Information on Mortality Rates with the AneuRx Stent Graft System

Patients should meet the appropriate risk-benefit profile...

Mistakenly Swallowing Inhaler Capsules
Respiratory problems will not be treated if patients mistakenly take the capsules orally rather than with an inhaler...

Choosing the Correct Test Strip for a Blood Glucose Meter
Using the wrong strip in any brand of blood glucose meter could result in erroneous readings or no readings at all...

For more FDA Patient Safety News, visit http://www.fda.gov/psn . Please send any comments, questions or suggestions about the program to PSNews@fda.gov


Update: 9
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 6 May 2008 10:36:07 -0500 (CDT)
Subject: FDA MedWatch- Cardinal Health Alcohol-Free Mouth- Product Recalled Because Of the Presence Of Burkholderia Cepacia

MedWatch logo MedWatch - The FDA Safety Information and Adverse Event Reporting Program

Hydrox Labs issued a voluntary recall of Cardinal Health labeled alcohol-free mouthwash because the product was found to contain Burkholderia cepacia (B. cepacia). The affected product lot number is 26228. B. cepacia poses little medical risk to healthy individuals. However, people who have certain health problems such as weakened immune systems or chronic lung diseases, particularly cystic fibrosis, may be more susceptible to infections with this organism. Consumers and facilities with the recalled alcohol-free mouthwash should stop using the product and contact Cardinal Health for instructions on how to return the product.

Read the entire 2008 MedWatch Safety Summary, including a link to the manufacturer's press release regarding this issue at:

http://www.fda.gov/medwatch/safety/2008/safety08.htm#Cardinal


This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

Monday, April 14, 2008

U.S. Food & Drug Administration (FDA) Daily Digest Bulletin date 11/01/08

Update : 1

Subject: CDRH New Update

Skip NavigationFDA Logo links to FDA home pageCenter for Devices and Radiological Health, U.S. Food and Drug AdministrationHHS Logo links to Department of Health and Human Services website

FDA Home Page | CDRH Home Page | Search | A-Z Index U.S. Food and Drug AdministrationCenter for Devices and Radiological Health Questions?
horizonal rule
CDRHNEW Logo Date: April 11, 2008

The following new items were added to the CDRH web pages on April 10, 2008. Previous CDRH New Items can be found on the CDRHNew Page.

* Federal Register: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medical Device User Fee Amendments of 2007; Foreign Small Business Qualification Certification, Form FDA 3602A. Text PDF
* FDA & YOU - News for Health Educators and Students - Spring 2008 Text
* Ophthalmic Devices Panel Advisory Meeting, April 24-25, 2008 - Waivers for Conflicts of Interest Text
* Orthopaedic and Rehabilitation Devices Panel Advisory Meeting, July 17, 2007 - Minutes Text
* Radiological Devices Panel Advisory Meeting, March 4-5, 2008 - Minutes Text

---


Update : 2

Subject: Herbal Science International, Inc. Recalls Twelve Dietary Herbal Supplements Nationwide Because of Possible Health Risk Associated with Ephedra, Aristolochic Acid and Human Placenta (April 10)

Herbal Science International, Inc. Recalls Twelve Dietary Herbal Supplements Nationwide Because of Possible Health Risk Associated with Ephedra, Aristolochic Acid and Human Placenta (April 10)
Fri, 11 Apr 2008 07:49:00 -0500

Herbal Science International, Inc. (AKA Jen-On Herbal Science International, Inc.) is recalling twelve dietary supplements that contain ephedra, aristolochic acid or human placenta because they may present a serious health hazard to consumers.


Update : 3

Subject: REQUESTED INFORMATION: NEW ISSUE OF FDA & YOU

The new issue of FDA & YOU is now available at www.fda.gov/cdrh/fdaandyou.

In this issue:

· Get to Know Staph (with optional Lesson Plan)

· Microwave Ovens: What you need to know before you get cooking

· Learn About It Online: Food Allergies

· Calendar of National Health Events

Be on the lookout for the FDA & YOU Customer Satisfaction Survey coming soon! This short survey will give you the chance to tell us what you think about FDA & YOU.

FDA & YOU is an e-newsletter dedicated to providing the latest FDA medical product and health information for teens, parents, and educators.

To recommend the FDA & YOU email service to friends, please forward this email to them or ask them to visit the FDA & YOU homepage to sign up.

Happy reading!
The Editors,

FDA & YOU



Update : 4

Subject: A Guide to Drug Safety Terms at FDA

A Guide to Drug Safety Terms at FDA
Fri, 11 Apr 2008 10:18:00 -0500

This guide offers descriptions of some of the more common drug safety terms used by FDA throughout the life cycle of a drug.


Update : 5

Subject: Find the Latest Drug Product and Safety Information

Find the Latest Drug Product and Safety Information
Fri, 11 Apr 2008 10:18:00 -0500

Resources for keeping up with the latest drug safety information from FDA.


Update : 6

Subject: Recent Device Approvals: CONTAK RENEWAL® 3 AVT® Cardiac Resynchronization Defibrillator (CRT-D)

Information about the CONTAK RENEWAL® 3 AVT® Cardiac Resynchronization Defibrillator (CRT-D), Models M150, M155, M157, and M159 has recently been posted to the FDA website, and is now available.


Update : 7

Subject: CDER's Small Business Assistance Bulletin

Small Business Assistance (SBA) in the Center for Drug Evaluation and Research (CDER) provides assistance to businesses with less than 500 employees in the development of new pharmaceutical products. Through an extensive outreach program SBA provides guidance and information to small pharmaceutical businesses through its ListServ, Q&A's, workshops, and website. The ListServ provides current information from CDER/FDA via e-mail on a biweekly basis that is relevant to small pharmaceutical businesses which includes Federal Register notices, guidances, workshop announcements, etc. The following information is being sent to you via e-mail.

1. FDA Small Pharmaceutical Business Assistance Educational Forum Public Workshop April 29, 2008 The Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER), Small Business Assistance will have a public workshop on April 29, 2008. from 8:00 a.m. to 5:00 p.m in Dallas Texas. There is no registration fee. The workshop is to provide information to small pharmaceutical businesses about FDA's premarket requirements; good manufacturing practices; OTC and generic drug issues. http://www.fda.gov/cder/about/smallbiz/SBAworkshop2008.htm

2. Prescription Drug User Fee Act (PDUFA) IV Drug Safety Five-Year Plan--Draft Document.

The purpose of this document is to communicate FDA’s strategy for meeting the commitments for enhancing and modernizing the drug safety system within the context of the PDUFA IV program. FDA will use this plan to:

Communicate strategies FDA will follow for using PDUFA IV drug safety resources;

Communicate our current activity and establish measures to report progress; and

Provide FDA leadership and management a foundation for understanding planned PDUFA IV drug safety activities. http://www.fda.gov/cder/pdufa/PDUFA_IV_5yr_plan_draft.pdf

3. FDA and Generic Drugs Interactive Forum June 30 – July 1, 2008, Bethesda, Md. This conference will provide information on how to and how not to communicate with the Office of Generic Drugs (OGD). You will also hear from generic industry peers about real life examples of experiences with OGD staff and their suggestions for a better way to communicate. http://www.pharmaconference.com/pharmaceutical_conferences/p_conf_brochures/June06_2008.pdf

4. New Guidance: Pharmacogenetics, Genomic Data and Sample Coding Categories The Food and Drug Administration published a notice in the Federal Register notice of April 8, 2008, regarding a guidance on Parmacogenetics, Genomic Data and Sample Coding Categories. This guidance contains definitions of key terms in the discipline of pharmacogenomics and pharmacogenetics, namely genomic biomarkers, pharmacogenomics, pharmacogenetics, and genomic data and sample coding categories. This guidance on definitions is intended to facilitate the integration of the discipline of pharmacogenomics and pharmacogenetics into global drug development and approval processes. As new scientific knowledge in the discipline of pharmacogenomics and pharmacogenetics emerges, the current guidance will be reviewed and expanded if appropriate. http://www.fda.gov/OHRMS/DOCKETS/98fr/FDA-2008-D-0199-gdl.pdf and http://www.fda.gov/OHRMS/DOCKETS/98fr/E8-7237.pdf

5. Identification of Drug and Biological Products Deemed to Have Risk Evaluation and Mitigation Strategies for Purposes of the Food and Drug Administration Amendments Act of 2007. The Food and Drug Administration (FDA) published a Federal Register notice on March 27, 2008, notifying holders of certain prescription new drug and biological license applications that they will be deemed to have in effect an approved risk evaluation and mitigation strategy (REMS) under the Food and Drug Administration Amendments Act of 2007 (FDAAA). Holders of applications deemed to have in effect an approved REMS are required to submit a proposed REMS to FDA. http://www.fda.gov/OHRMS/DOCKETS/98fr/E8-6201.pdf

6. Draft Guidance on Genotoxicity Testing and Data Interpretation for PharmaceuticalsIntended for Human Use The Food and Drug Administration published a notice in the Federal Register of March 26, 2008, regarding a guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use. The draft guidance is intended to help facilitate drug development programs, ensure patient safety, and reduce animal usage. http://www.fda.gov/OHRMS/DOCKETS/98fr/08-1076.pdf and http://www.fda.gov/OHRMS/DOCKETS/98fr/FDA-2008-D-0178-GDL.pdf

7. The remarks by Andrew C. von Eschenbach, M.D., Commissioner of Food and Drugs on The FDA Amendments Act: Reauthorization of the FDA.
Food and Drug Law Institute Washington, D.C. March 26, 2008. http://www.fda.gov/oc/speeches/2008/fdli032608.html

8. NLM and ORWH Announce New NIH Web Site Source for Women's Health Research Information A new Web resource providing the latest information on significant topics in women's health research from scientific journals and other peer-reviewed sources is now available through the National Library of Medicine (NLM). The NLM, of the National Institutes of Health (NIH), through its Division of Specialized Information Services, Office of Outreach and Special Populations has partnered with the NIH Office of Research on Women's Health (ORWH) to create this one-stop resource. http://www.nih.gov/news/health/mar2008/od-10.htm

Ron Wilson Director of Small Business Assistance wilsonr@cder.fda.gov


Update : 8

Subject: Salmonella Illnesses in Multiple States may be Linked to Recently Recalled Cereal

Salmonella Illnesses in Multiple States may be Linked to Recently Recalled Cereal
Sat, 12 Apr 2008 13:40:00 -0500

The recalled products were distributed nationally under the Malt-O-Meal brand name as well as under private label brands including Acme, America's Choice, Food Club, Giant, Hannaford, Jewel, Laura Lynn, Pathmark, Shaw's, ShopRite, Tops and Weis Quality. The cereals have "Best If Used By" dates from April 8, 2008 (coded as "APR0808") through March 18, 2009 (coded as "MAR1809").


This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420